Yee Lung Ong

CIK: 0002081473

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (60.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CYCC

Cyclacel Pharmaceuticals, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (5 total)

BGMS
Bio Green Med Solution, Inc.
Nov 5, 2025
Other(J)
Direct
467.5K shares-
BGMS
Bio Green Med Solution, Inc.
Oct 30, 2025
Sale(S)
Direct
248.8K shares at avg. $1.80$448K
BGMS
Bio Green Med Solution, Inc.
Oct 24, 2025
Sale(S)
Direct
19.9K shares at avg. $1.99$40K
BGMS
Bio Green Med Solution, Inc.
Oct 14, 2025
Sale(S)
Direct
135.8K shares at avg. $6.00$815K
CYCC
Cyclacel Pharmaceuticals, Inc.
Sep 4, 2025
Other(J)
Direct
186.5K shares-

		Type	Shares	Price		Ownership
Nov 5, 2025	BGMS Bio Green Med Solution, Inc.	Other(J)	467,535	-	-	Direct
Oct 30, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	248,814	$1.80	$447,865	Direct
Oct 24, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	19,858	$1.99	$39,517	Direct
Oct 14, 2025	BGMS Bio Green Med Solution, Inc.	Sale(S)	135,793	$6.00	$814,758	Direct
Sep 4, 2025	CYCC Cyclacel Pharmaceuticals, Inc.	Other(J)	186,465	-	-	Direct

1-5 of 5 transactions

About Ong Yee Lung

Ong Yee Lung (SEC CIK 0002081473) files insider reports with the SEC as 10% Owner of Cyclacel Pharmaceuticals, Inc. (CYCC).

Signal8 holds 6 ownership filings by Ong Yee Lung (1 Form 3, 5 Form 4), filed between Sep 2, 2025 and Nov 5, 2025. Those filings report 5 transactions, from Sep 4, 2025 to Nov 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Ong Yee Lung's filings is in JOHOR BAHRU, N8.

Recent filings by Ong Yee Lung

Nov 5, 2025: Other transaction of BGMS shares (Form 4, code J).
Oct 30, 2025: Open-market sale of BGMS shares (Form 4, code S).
Oct 24, 2025: Open-market sale of BGMS shares (Form 4, code S).
Oct 14, 2025: Open-market sale of BGMS shares (Form 4, code S).
Sep 4, 2025: Other transaction of CYCC shares (Form 4, code J).

Other insiders filing for Cyclacel Pharmaceuticals, Inc. (CYCC)

Kiu Cu Seng, CFO and Secretary
Doris Wong Sing Ee, Chief Executive Officer
Yap Kim Choy, 10% Owner
Kua Khai Loon, 10% Owner
Lazar David E., Interim CEO
Tan Kok Hui, 10% Owner

How to read Form 4 transaction codes